CD8A and neoplasm: The PD-1/PD-L1 checkpoint works as an inhibitory signal when a CD8+ cell recognize a tumor cell, and blocking this signal with αPD-1 or αPD-L1 antibodies increases CD8+ mediated tumor cell death (1).